Renal Cell Carcinoma, Metastatic
Oncology
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| Aybintio (SB8) | Organon & Co. (OGN) |
Frequently asked questions
How many drugs are in development for Renal Cell Carcinoma, Metastatic?
BioSniper tracks 1 drug in development for Renal Cell Carcinoma, Metastatic across 1 company.
How many clinical trials target Renal Cell Carcinoma, Metastatic?
There are 1 clinical trial targeting Renal Cell Carcinoma, Metastatic tracked by BioSniper.
Analyze Organon & Co.'s Renal Cell Carcinoma, Metastatic pipeline with AI
Full trial data, competitive analysis, and AI-powered pipeline tracking.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company